InternationalScored off the official board: an annual-only filer, so this data lags a domestic quarterly filer.

13F Pro Quality Score

38.8/100

Rank #2,173 of 2,960 stocks

View Healthcare peers →

Rankings refresh quarterly once 80% of peers have filed (~45 days after quarter-end). Next update: ~Nov 14, 2026.

Email me the moment this company reports earnings
AI Research Report
Two-page plain-English analysis: business, thesis, and three scenarios for the next two years. Refreshed every quarter.
Upgrade to Pro
Pro: 5 reports/month · Pro+: unlimitedOpinion, not investment advice. Do your own research.

BWAY Stock Analysis & AI Quality Score

Data updated 2026-09-12

AI stock analysis and institutional research for Brainsway Ltd. (BWAY), a Healthcare sector company. 13F Pro's AI-powered ranking engine scores BWAY at 38.8/100 on a 32-signal composite quality model, placing it at rank #2,173 of 2,960 stocks — the bottom half of the AI-ranked universe. Top institutional holders of BWAY by reported 13-F value include Valor Management, MASTERS CAPITAL MANAGEMENT, ACADIAN ASSET MANAGEMENT, based on the most recent SEC filings. BWAY trades on the Nasdaq exchange and files with the SEC under CIK 1505065. 13F Pro's AI research platform runs 10 specialized AI analysts — value, growth, momentum, macro, and activist specialists — that debate BWAY daily and publish AI-generated analysis with cited SEC sources. The platform aggregates historical XBRL financial facts, 10-Q and 10-K filings, insider Form 4 transactions, and institutional 13-F holdings for Brainsway Ltd. directly from SEC EDGAR. Brainsway Ltd.'s 13F Pro composite quality score has ranged between 39 and 43 since 2026, currently 38.8 — a declining long-term trajectory across 48 quarterly and live scoring snapshots.

Period

Revenue & Net Income

Earnings Per Share

Key Financials Over Time

Export Financial Table · Pro

Revenue

+29.0% YoY
$41.0MFY 2024
FY21 $29.7MFY22 $27.2MFY23 $31.8MFY24 $41.0M

Total Assets

+49.8% YoY
$94.3MFY 2024
FY21 $75.7MFY22 $64.5MFY23 $63.0MFY24 $94.3M

Get alerted when BWAY's score changes

Free account: watchlist tracking, the daily AI brief, and the AI screener.

Passwordless sign-in · Payments by Stripe · Auth by Clerk

Available Research

13F Pro tracks comprehensive data for Brainsway Ltd. including:

SEC EDGAR filings (10-K, 10-Q, 8-K)
XBRL financial facts (revenue, EPS, margins)
Insider transactions (Form 4)
Institutional 13F holdings
Quality rankings (32 signals)
AI analyst debates & daily meetings
Historical financial trends
Peer comparison & sector analysis

Companies Similar to BWAY

Ranked by quality-profile closeness and shared hedge-fund ownership — not just sector membership.

AUNA

AUNA S.A.

36
AI score
Similar quality profile
STVN

Stevanato Group S.p.A.

42
AI score
Similar quality profile · 1 shared holders
APT

ALPHA PRO TECH LTD

46
AI score
Similar quality profile · 1 shared holders
FONR

FONAR CORP

40
AI score
Similar quality profile
KMDA

KAMADA LTD

53
AI score
Similar quality profile · 3 shared holders
GSK

GSK plc

44
AI score
Similar quality profile
PHG

KONINKLIJKE PHILIPS NV

40
AI score
Similar quality profile
HRMY

Harmony Biosciences Holdings, Inc.

69
AI score
Similar quality profile · 3 shared holders

Similarity is computed from the 8 composite sub-scores and latest-quarter 13F conviction holdings (index-style filers excluded). Refreshed monthly.

Put BWAY on your watchlist

Track score changes the day Brainsway Ltd. files with the SEC, follow the hedge funds that own it, screen 2,800+ AI-scored stocks, and get the daily brief — free.

View Pricing

Free tier includes 13F data, economic indicators, and market overview. Pro starts at $6.67/mo (billed annually).

Passwordless sign-in · Payments by Stripe · Auth by Clerk

Is BWAY a good stock to buy?

13F Pro's AI-powered analysis of Brainsway Ltd. (BWAY) draws on SEC EDGAR-sourced fundamentals, institutional 13F holdings, and insider Form 4 transactions in the Healthcare sector (listed on Nasdaq). The 32-signal AI Quality Score, current rank, and full bull/bear verdict for BWAY are available on the BWAY stock profile dashboard — with the same data, AI insights, ratios, and institutional activity refreshed after every 10-K, 10-Q, 13F, and Form 4 filing. BWAY is classified as a small company.

Which hedge funds own BWAY?

Institutional investors are required to disclose their holdings quarterly via SEC Form 13F. 13F Pro aggregates these filings to show which hedge funds, mutual funds, and asset managers are buying or selling BWAY. Combined with insider transaction data from Form 4 filings and AI-powered analysis from 10 specialized research agents, 13F Pro provides a comprehensive view of Brainsway Ltd.'s investment landscape.